JOHNSON & JOHNSON

JNJ
Real-time Estimate Cboe BZX - 10:45 2022-12-07 am EST
177.10 USD +0.57%

Turn to zoom
Prev.176.10000000
Open176.57000000
High177.75500000
Low176.23000000
Volume7 610 102
Latest news
13m ago
6h ago
20h ago
1d ago
Chart JOHNSON & JOHNSON
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance179182182
Spread/Res.-0,63%-2,5%-2,5%
Spread/Supp.1,6%11%11%
Support175160160
Financials
Sales 2022 95 035 M - -
Net income 2022 20 677 M - -
Net cash 2022 10 806 M - -
P/E ratio 2022 21,6x
Yield 2022 2,47%
Capitalization 460 B 460 B -
EV / Sales 2022 4,73x
EV / Sales 2023 4,51x
Nbr of Employees 141 700
Free-Float 83,8%
Company
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (55.5%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious,...
Sector :
Other Pharmaceuticals
Calendar :
2023-01-24 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 176,10 $
Average target price 181,81 $
Spread / Average Target 3,24%